Latest Post

January 06, 2021

West Presented on China Registrations for Combination Products at Annual ISPE Meeting & Expo

On <span>November 6, 2020</span>, West&rsquo;s Regulatory Affairs Senior Director, Lynn Lundy, presented at the 2020 ISPE (International Society for Pharmaceutical Engineering) Annual Meeting and Expo. The week-long virtual meeting focused on steering the future of pharmaceutical science and manufacturing toward a more global, synchronized, and quality-driven industry. Pharmaceutical and biopharmaceutical professionals from drug manufacturing, supply chain, devices and equipment and services, and global regulatory agencies were in attendance to discuss hot topics such as Data Integrity, Covid-19 Impact, Combination Products and more.
Katie Casale

Katie Casale

Associate Specialist, Regulatory Affairs

Previous Posts
Stoppers

December 17, 2020

Guideline for Nitrosamine Impurities in China

Candice Sun

Candice Sun

Specialist, Scientific Affairs, CN

Stoppers

November 20, 2020

New USP Chapters , , , and

Daniel Bantz

Daniel Bantz

Manager, Scientific Communications, Self Injection Systems

Requirements and Standards icon

November 11, 2020

Global Compendial and Standards Requirements for Elastomeric Components

Bettine Boltres

Bettine Boltres

Principal, Scientific Affairs & TCS EU

Bettine Boltres presents at PDA Webinar

August 24, 2020

How to Include Elastomers in the Nitrosamine Risk Assessment

Bettine Boltres

Dr. Bettine Boltres

Principal Scientific Affairs, Packaging & Delivery Systems

Load more